Division of Gastroenterology and Hepatology, Loma Linda University Health, Loma Linda, California.
Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, Oregon.
Gastroenterology. 2023 May;164(6):906-920. doi: 10.1053/j.gastro.2023.01.027. Epub 2023 Feb 2.
BACKGROUND & AIMS: The use of computer-aided detection (CAD) increases the adenoma detection rates (ADRs) during colorectal cancer (CRC) screening/surveillance. This study aimed to evaluate the requirements for CAD to be cost-effective and the impact of CAD on adenoma detection by endoscopists with different ADRs.
We developed a semi-Markov microsimulation model to compare the effectiveness of traditional colonoscopy (mean ADR, 26%) to colonoscopy with CAD (mean ADR, 37%). CAD was modeled as having a $75 per-procedure cost. Extensive 1-way sensitivity and threshold analysis were performed to vary cost and ADR of CAD. Multiple scenarios evaluated the potential effect of CAD on endoscopists' ADRs. Outcome measures were reported in incremental cost-effectiveness ratios, with a willingness-to-pay threshold of $100,000/quality-adjusted life year.
When modeling CAD improved ADR for all endoscopists, the CAD cohort had 79 and 34 fewer lifetime CRC cases and deaths, respectively, per 10,000 persons. This scenario was dominant with a cost savings of $143 and incremental effectiveness of 0.01 quality-adjusted life years. Threshold analysis demonstrated that CAD would be cost-effective up to an additional cost of $579 per colonoscopy, or if it increases ADR from 26% to at least 30%. CAD reduced CRC incidence and mortality when limited to improving ADRs for low-ADR endoscopists (ADR <25%), with 67 fewer CRC cases and 28 CRC deaths per 10,000 persons compared with traditional colonoscopy.
As CAD is implemented clinically, it needs to improve mean ADR from 26% to at least 30% or cost less than $579 per colonoscopy to be cost-effective when compared with traditional colonoscopy. Further studies are needed to understand the impact of CAD when used in community practice.
计算机辅助检测(CAD)的使用提高了结直肠癌(CRC)筛查/监测期间的腺瘤检出率(ADR)。本研究旨在评估 CAD 的成本效益要求,以及不同 ADR 的内镜医师使用 CAD 对腺瘤检出的影响。
我们开发了一个半马尔可夫微模拟模型,以比较传统结肠镜检查(平均 ADR,26%)与 CAD 结肠镜检查(平均 ADR,37%)的效果。CAD 的建模费用为每次 75 美元。进行了广泛的单因素敏感性和阈值分析,以改变 CAD 的成本和 ADR。多个方案评估了 CAD 对内镜医师 ADR 的潜在影响。结果以增量成本效益比报告,支付意愿阈值为 10 万美元/质量调整生命年。
当 CAD 提高所有内镜医师的 ADR 时,CAD 组每 10000 人终生 CRC 病例和死亡人数分别减少 79 例和 34 例。这种方案具有成本节约 143 美元和增量效果 0.01 质量调整生命年的优势。阈值分析表明,CAD 的成本效益高达每次结肠镜检查额外增加 579 美元,或者如果它将 ADR 从 26%提高到至少 30%。CAD 通过提高低 ADR 内镜医师(ADR<25%)的 ADR,降低 CRC 的发病率和死亡率,与传统结肠镜检查相比,每 10000 人有 67 例 CRC 病例和 28 例 CRC 死亡。
随着 CAD 在临床上的实施,它需要将平均 ADR 从 26%提高到至少 30%,或者每次结肠镜检查的成本低于 579 美元,才能与传统结肠镜检查相比具有成本效益。需要进一步的研究来了解 CAD 在社区实践中使用的影响。